Seminars in Urologic Oncology
container_q5cq7afc2jefdnpatdlyqum4uy
Elsevier - WB Saunders
Showing first 25 out of 311 results
Emphasizing and promoting overall health and nontraditional treatments after a prostate cancer diagnosis
no archive
M A Moyad
1999
|
Seminars in Urologic Oncology
pmid:10332926
Indications for early cystectomy
no archive
J P Stein
2000
|
Seminars in Urologic Oncology
pmid:11101092
Prostate Cancer Shared Decision: a CD-ROM educational and decision-assisting tool for men with prostate cancer
no archive
A DePalma
2000
|
Seminars in Urologic Oncology
pmid:10975488
Minimal toxicity with 3-FAT radiotherapy of prostate cancer
no archive
M D Weil, E D Crawford, P Cornish, W Dzingle, K Stuhr, B Pickett, M Roach
2000
|
Seminars in Urologic Oncology
pmid:10875453
Chemotherapy for good-risk germ-cell tumors
no archive
Charles J. Ryan, Dean F. Bajorin
2002
|
Seminars in Urologic Oncology
doi:10.1053/suro.2002.37208 pmid:12489057 wikidata:Q35028964
The role of chemotherapy in the management of the patient with T3b bladder cancer
no archive
R Millikan, C P Dinney
1996
|
Seminars in Urologic Oncology
pmid:8734735
Artificial neural networks for diagnosis and prognosis in prostate cancer
no archive
Guido Schwarzer, Martin Schumacher
2002
|
Seminars in Urologic Oncology
doi:10.1053/suro.2002.32492
Radiotherapy of T1c prostate cancer
no archive
E Ben-Josef, A T Porter
1995
|
Seminars in Urologic Oncology
pmid:8521132
Decision-making strategies for patients with localized prostate cancer
no archive
Michael A Diefenbach, Jenevie Dorsey, Robert G Uzzo, Gerald E Hanks, Richard E Greenberg, Eric Horwitz, Fredrick Newton, Paul F Engstrom
2002
|
Seminars in Urologic Oncology
pmid:11828358
Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001
no archive
Aruna V Sarma, David Schottenfeld
2002
|
Seminars in Urologic Oncology
pmid:11828352
Staging and prognosis of T3b bladder cancer
no archive
D A Levy, H B Grossman
1996
|
Seminars in Urologic Oncology
pmid:8734732
The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy
no archive
C D Young, P Lewis, V Weinberg, T T Lee, C W Coleman, M Roach
2000
|
Seminars in Urologic Oncology
pmid:10875452
Dose intensity: its limitation and the M. D. Anderson Cancer Center's view of its application
dark archive
R J Amato
1998
|
Seminars in Urologic Oncology
pmid:9649232
T3 prostate cancer: how reliable is clinical staging?
dark archive
V Ravery, L Boccon-Gibod
1997
|
Seminars in Urologic Oncology
pmid:9421446
Anatomic basis for the continence-preserving radical retropubic prostatectomy
no archive
M S Steiner
2000
|
Seminars in Urologic Oncology
pmid:10719925
Preoperative estimate of extent of disease in T1c: how well can we predict?
no archive
M S Austenfeld
1995
|
Seminars in Urologic Oncology
pmid:8521129
Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors
no archive
G. Varuni Kondagunta, Robert J. Motzer
2002
|
Seminars in Urologic Oncology
doi:10.1053/suro.2002.36975 pmid:12489056 wikidata:Q35028960
Radical prostatectomy and collaborative care pathways
no archive
J M Holzbeierlein, J A Smith
2000
|
Seminars in Urologic Oncology
pmid:10719934
Radiotherapy for stage T3b transitional cell carcinoma of the bladder
no archive
A Pollack, G Z Zagars
1996
|
Seminars in Urologic Oncology
pmid:8734736
Vitamin E, alpha- and gamma-tocopherol, and prostate cancer
no archive
M A Moyad, S K Brumfield, K J Pienta
1999
|
Seminars in Urologic Oncology
pmid:10332921
Radical cystectomy for stage T3b bladder cancer
no archive
C M Hall, C P Dinney
1996
|
Seminars in Urologic Oncology
pmid:8734734
The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer
dark archive
A L Zietman, W U Shipley, N M Heney, A F Althausen
1997
|
Seminars in Urologic Oncology
pmid:9394911
Wilms' tumor. Introduction
no archive
J H Ross, R Kay
1999
|
Seminars in Urologic Oncology
pmid:10073399
The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Societe Internationale d'Oncologie Pediatrique
no archive
J Godzinski, M F Tournade, J De Kraker, R Ludwig, A Weirich, P A Voute, J M Burgers, J L Habrand, B Sandstedt, M Ducourtieux
1999
|
Seminars in Urologic Oncology
pmid:10073403
The role of preoperative chemotherapy for Wilms' tumor: the NWTSG perspective. National Wilms' Tumor Study Group
no archive
M L Ritchey
1999
|
Seminars in Urologic Oncology
pmid:10073402
« Previous
Showing results 0 — 25 out of 311 results
Next »